Apollon Wealth Management’s Clearside Biomedical CLSD Stock Holding History

Apollon Wealth Management’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,586	Closed	-$93.6K	–	1320
2025 Q3	$93.6K	Buy	+23,586	New	+$161K	﹤0.01%	1271

Other funds holding CLSD

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Apollon Wealth Management's CLSD Position: Q4 2025 in Review

Apollon Wealth Management sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 23,586 shares — an estimated $93.6K sold.

Apollon Wealth Management first reported a position in CLSD in Q3 2025 and held it in 1 quarter. The position peaked at $93.6K in Q3 2025. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.

Apollon Wealth Management reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
Apollon Wealth Management sold 23,586 Clearside Biomedical shares in Q4 2025, an estimated $93.6K.
Apollon Wealth Management first reported a position in Clearside Biomedical in Q3 2025 and held it in 1 quarter.
Apollon Wealth Management's Clearside Biomedical position peaked at $93.6K in Q3 2025.
1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.

Based on Apollon Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.